The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Terns Pharmaceuticals(NASDAQ:TERN) 
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and other chronic liver diseases. It develops TERN-101, a liver-distributed and non-bile acid far...
Share this website to your friends
Terns Pharmaceuticals Days Payable Outstanding ttm (DPO)
Terns Pharmaceuticals Op Cashflow Per Share ttm
Terns Pharmaceuticals Free Cashflow Per Share ttm
Terns Pharmaceuticals Cash Per Share ttm
Terns Pharmaceuticals P/S ratio ttm
Terns Pharmaceuticals (GAAP) P/E ratio ttm
Terns Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.